NASDAQ:CACB Cascade Bancorp (CACB) Stock Price, News & Analysis → The Petrodollar Scheme Comes to an End (From Colonial Metals) (Ad) Free CACB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$6.99▼$6.9950-Day Range N/A52-Week Range$5.27▼$8.52VolumeN/AAverage Volume150,754 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cascade Bancorp alerts: Email Address Ad Colonial MetalsThe Petrodollar Scheme Comes to an EndThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. About Cascade Bancorp Stock (NASDAQ:CACB)Cascade Bancorp is a United States-based bank holding company. The Company operates through its subsidiary, Bank of the Cascades (the Bank). The Bank is an Oregon state chartered bank. The Bank offers a range of commercial and retail banking services to its customers. It provides commercial real estate loans, real estate construction and development loans, and commercial and industrial loans, as well as consumer installment, line-of-credit, credit card and home equity loans. It also originates residential mortgage loans. It provides consumer and business deposit services, including checking, money market, time deposit accounts and related payment services, Internet banking, electronic bill payment and remote deposits. It provides trust and investment related services. As of December 31, 2015, the Bank operated 37 branches serving communities in Central, Southern and Northwest Oregon, as well as in the greater Boise/Treasure Valley, Idaho and Seattle, Washington areas.Read More Ad Colonial MetalsThe Petrodollar Scheme Comes to an EndThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. CACB Stock News HeadlinesApril 13, 2024 | ft.comParisian collective aims to put female artists on a firm financial footingDecember 2, 2023 | nasdaq.comCommit To Buy The Bancorp At $30, Earn 6.8% Annualized Using OptionsNovember 4, 2023 | morningstar.comConnectOne Bancorp Inc CNOBOctober 1, 2023 | seekingalpha.comCustomers Bancorp stock jumps on new Strong Buy rating at RayJaySeptember 8, 2023 | seekingalpha.comMore on New York Community Bancorp Deposit Shs Repr Non Cum Perp Pfd Registered Series AAugust 5, 2023 | nasdaq.comU.S. Bancorp Common Stock (USB)April 7, 2023 | seekingalpha.comU.S. Bancorp And Truist: Are The True Extent Of Losses Hidden?April 6, 2023 | nasdaq.comRelative Strength Alert For Hope BancorpApril 3, 2023 | thestreet.com5 Shorted Bank Stocks Set to ClimbMarch 26, 2023 | bloomberg.comSidhu’s Customers Bancorp Weighs Making an Offer for Silicon Valley BankMarch 16, 2023 | thestreet.comMore Banks, Thrifts Join Watch ListFebruary 27, 2023 | thestreet.comFinancial Winners and Losers: MorganFebruary 22, 2023 | markets.businessinsider.comHere's what Wall Street expects from Boise Cascade LLC's earningsSeptember 24, 2022 | mirror.co.ukApocalyptic cascade of Russian incendiary bombs rains down on Ukrainian villageFebruary 23, 2022 | thestreet.comUndercapitalized Bank List Still GrowingSee More Headlines Receive CACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cascade Bancorp and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/25/2017Today6/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryRegional Banks Current SymbolNASDAQ:CACB CUSIP14715420 CIK865911 Webwww.snl.com Phone+1-541-3856205FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesRyan Ralph Patrick CPAChairman of the BoardTerry E. ZinkPresident, Chief Executive Officer, Director of the Company and BankGregory D. NewtonChief Financial Officer, Executive Vice PresidentPeggy L. BissExecutive Vice President, Chief Administrative Officer of the company and Bank.Daniel J. LeeExecutive Vice President and Chief Credit Officer of Cascade Bancorp and BankCharles N. ReevesExecutive Vice President, Chief Banking OfficerAnnette G. ElgDirectorDennis L. JohnsonDirectorPatricia L. MossDirectorJerol Eugene AndresIndependent DirectorMore ExecutivesKey CompetitorsSusquehanna BancsharesNASDAQ:SUSQThe PNC Financial Services GroupNYSE:PNCTruist FinancialNYSE:TFCFifth Third BancorpNASDAQ:FITBM&T BankNYSE:MTBView All Competitors CACB Stock Analysis - Frequently Asked Questions How were Cascade Bancorp's earnings last quarter? Cascade Bancorp (NASDAQ:CACB) announced its quarterly earnings data on Tuesday, April, 25th. The financial services provider reported $0.09 EPS for the quarter, beating the consensus estimate of $0.09 by $0.00. The financial services provider had revenue of $32.34 million for the quarter, compared to analyst estimates of $33.88 million. During the same quarter in the previous year, the firm posted $0.03 earnings per share. What other stocks do shareholders of Cascade Bancorp own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cascade Bancorp investors own include Avon Products (AVP), Netlist (NLST), Acer Therapeutics (ACER), Achillion Pharmaceuticals (ACHN), Axcelis Technologies (ACLS), Acasti Pharma (ACST), Authentidate (ADAT), Aeterna Zentaris (AEZS), Agenus (AGEN) and Albireo Pharma (ALBO). This page (NASDAQ:CACB) was last updated on 6/5/2024 by MarketBeat.com Staff From Our PartnersWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises| SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals| SponsoredForget the Kitty! 7 stocks better than GME or AMCIn 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club| Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC| SponsoredWhat’s Pelosi Buying Now?They Make the Top Investors Look Like Amateurs They beat the market for three years straight… avoided some ...Altimetry| SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media| SponsoredClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an eff...Crypto Swap Profits| SponsoredAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro| Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cascade Bancorp Please log in to your account or sign up in order to add this asset to your watchlist. Share Cascade Bancorp With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.